Medical Care

Global Gene Vector Market Research Report 2025

The global market for Gene Vector was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Gene Vector is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Gene Vector is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Gene Vector in Scientific Research is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Gene Vector include Lonza, Merck KGaA, Oxford Biomedica, CGT Catapult, Charles River Laboratories, uniQure N.V., FUJIFILM Diosynth Biotechnologies, Spark Therapeutics, Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Gene Vector, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Vector.
The Gene Vector market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gene Vector market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Vector companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
Merck KGaA
Oxford Biomedica
CGT Catapult
Charles River Laboratories
uniQure N.V.
FUJIFILM Diosynth Biotechnologies
Spark Therapeutics, Inc.
Segment by Type
Lentivirus
Adenovirus
Adeno-associated Virus (AAV)
Plasmid DNA
Others
Segment by Application
Scientific Research
CRO
CDMO
Others (Pharmaceutical, Biotechnology Companies)
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Vector company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Vector Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Lentivirus
1.2.3 Adenovirus
1.2.4 Adeno-associated Virus (AAV)
1.2.5 Plasmid DNA
1.2.6 Others
1.3 Market by Application
1.3.1 Global Gene Vector Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Scientific Research
1.3.3 CRO
1.3.4 CDMO
1.3.5 Others (Pharmaceutical, Biotechnology Companies)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Vector Market Perspective (2020-2031)
2.2 Global Gene Vector Growth Trends by Region
2.2.1 Global Gene Vector Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Gene Vector Historic Market Size by Region (2020-2025)
2.2.3 Gene Vector Forecasted Market Size by Region (2026-2031)
2.3 Gene Vector Market Dynamics
2.3.1 Gene Vector Industry Trends
2.3.2 Gene Vector Market Drivers
2.3.3 Gene Vector Market Challenges
2.3.4 Gene Vector Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Vector Players by Revenue
3.1.1 Global Top Gene Vector Players by Revenue (2020-2025)
3.1.2 Global Gene Vector Revenue Market Share by Players (2020-2025)
3.2 Global Gene Vector Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Gene Vector Revenue
3.4 Global Gene Vector Market Concentration Ratio
3.4.1 Global Gene Vector Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Vector Revenue in 2024
3.5 Global Key Players of Gene Vector Head office and Area Served
3.6 Global Key Players of Gene Vector, Product and Application
3.7 Global Key Players of Gene Vector, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Vector Breakdown Data by Type
4.1 Global Gene Vector Historic Market Size by Type (2020-2025)
4.2 Global Gene Vector Forecasted Market Size by Type (2026-2031)
5 Gene Vector Breakdown Data by Application
5.1 Global Gene Vector Historic Market Size by Application (2020-2025)
5.2 Global Gene Vector Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Gene Vector Market Size (2020-2031)
6.2 North America Gene Vector Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Gene Vector Market Size by Country (2020-2025)
6.4 North America Gene Vector Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Vector Market Size (2020-2031)
7.2 Europe Gene Vector Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Gene Vector Market Size by Country (2020-2025)
7.4 Europe Gene Vector Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Vector Market Size (2020-2031)
8.2 Asia-Pacific Gene Vector Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Gene Vector Market Size by Region (2020-2025)
8.4 Asia-Pacific Gene Vector Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Vector Market Size (2020-2031)
9.2 Latin America Gene Vector Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Gene Vector Market Size by Country (2020-2025)
9.4 Latin America Gene Vector Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Vector Market Size (2020-2031)
10.2 Middle East & Africa Gene Vector Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Gene Vector Market Size by Country (2020-2025)
10.4 Middle East & Africa Gene Vector Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Gene Vector Introduction
11.1.4 Lonza Revenue in Gene Vector Business (2020-2025)
11.1.5 Lonza Recent Development
11.2 Merck KGaA
11.2.1 Merck KGaA Company Details
11.2.2 Merck KGaA Business Overview
11.2.3 Merck KGaA Gene Vector Introduction
11.2.4 Merck KGaA Revenue in Gene Vector Business (2020-2025)
11.2.5 Merck KGaA Recent Development
11.3 Oxford Biomedica
11.3.1 Oxford Biomedica Company Details
11.3.2 Oxford Biomedica Business Overview
11.3.3 Oxford Biomedica Gene Vector Introduction
11.3.4 Oxford Biomedica Revenue in Gene Vector Business (2020-2025)
11.3.5 Oxford Biomedica Recent Development
11.4 CGT Catapult
11.4.1 CGT Catapult Company Details
11.4.2 CGT Catapult Business Overview
11.4.3 CGT Catapult Gene Vector Introduction
11.4.4 CGT Catapult Revenue in Gene Vector Business (2020-2025)
11.4.5 CGT Catapult Recent Development
11.5 Charles River Laboratories
11.5.1 Charles River Laboratories Company Details
11.5.2 Charles River Laboratories Business Overview
11.5.3 Charles River Laboratories Gene Vector Introduction
11.5.4 Charles River Laboratories Revenue in Gene Vector Business (2020-2025)
11.5.5 Charles River Laboratories Recent Development
11.6 uniQure N.V.
11.6.1 uniQure N.V. Company Details
11.6.2 uniQure N.V. Business Overview
11.6.3 uniQure N.V. Gene Vector Introduction
11.6.4 uniQure N.V. Revenue in Gene Vector Business (2020-2025)
11.6.5 uniQure N.V. Recent Development
11.7 FUJIFILM Diosynth Biotechnologies
11.7.1 FUJIFILM Diosynth Biotechnologies Company Details
11.7.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.7.3 FUJIFILM Diosynth Biotechnologies Gene Vector Introduction
11.7.4 FUJIFILM Diosynth Biotechnologies Revenue in Gene Vector Business (2020-2025)
11.7.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.8 Spark Therapeutics, Inc.
11.8.1 Spark Therapeutics, Inc. Company Details
11.8.2 Spark Therapeutics, Inc. Business Overview
11.8.3 Spark Therapeutics, Inc. Gene Vector Introduction
11.8.4 Spark Therapeutics, Inc. Revenue in Gene Vector Business (2020-2025)
11.8.5 Spark Therapeutics, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Gene Vector Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Lentivirus
Table 3. Key Players of Adenovirus
Table 4. Key Players of Adeno-associated Virus (AAV)
Table 5. Key Players of Plasmid DNA
Table 6. Key Players of Others
Table 7. Global Gene Vector Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Gene Vector Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Gene Vector Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Gene Vector Market Share by Region (2020-2025)
Table 11. Global Gene Vector Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Gene Vector Market Share by Region (2026-2031)
Table 13. Gene Vector Market Trends
Table 14. Gene Vector Market Drivers
Table 15. Gene Vector Market Challenges
Table 16. Gene Vector Market Restraints
Table 17. Global Gene Vector Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Gene Vector Market Share by Players (2020-2025)
Table 19. Global Top Gene Vector Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Vector as of 2024)
Table 20. Ranking of Global Top Gene Vector Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Gene Vector Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Gene Vector, Headquarters and Area Served
Table 23. Global Key Players of Gene Vector, Product and Application
Table 24. Global Key Players of Gene Vector, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Gene Vector Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Gene Vector Revenue Market Share by Type (2020-2025)
Table 28. Global Gene Vector Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Gene Vector Revenue Market Share by Type (2026-2031)
Table 30. Global Gene Vector Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Gene Vector Revenue Market Share by Application (2020-2025)
Table 32. Global Gene Vector Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Gene Vector Revenue Market Share by Application (2026-2031)
Table 34. North America Gene Vector Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Gene Vector Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Gene Vector Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Gene Vector Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Gene Vector Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Gene Vector Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Gene Vector Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Gene Vector Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Gene Vector Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Gene Vector Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Gene Vector Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Gene Vector Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Gene Vector Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Gene Vector Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Gene Vector Market Size by Country (2026-2031) & (US$ Million)
Table 49. Lonza Company Details
Table 50. Lonza Business Overview
Table 51. Lonza Gene Vector Product
Table 52. Lonza Revenue in Gene Vector Business (2020-2025) & (US$ Million)
Table 53. Lonza Recent Development
Table 54. Merck KGaA Company Details
Table 55. Merck KGaA Business Overview
Table 56. Merck KGaA Gene Vector Product
Table 57. Merck KGaA Revenue in Gene Vector Business (2020-2025) & (US$ Million)
Table 58. Merck KGaA Recent Development
Table 59. Oxford Biomedica Company Details
Table 60. Oxford Biomedica Business Overview
Table 61. Oxford Biomedica Gene Vector Product
Table 62. Oxford Biomedica Revenue in Gene Vector Business (2020-2025) & (US$ Million)
Table 63. Oxford Biomedica Recent Development
Table 64. CGT Catapult Company Details
Table 65. CGT Catapult Business Overview
Table 66. CGT Catapult Gene Vector Product
Table 67. CGT Catapult Revenue in Gene Vector Business (2020-2025) & (US$ Million)
Table 68. CGT Catapult Recent Development
Table 69. Charles River Laboratories Company Details
Table 70. Charles River Laboratories Business Overview
Table 71. Charles River Laboratories Gene Vector Product
Table 72. Charles River Laboratories Revenue in Gene Vector Business (2020-2025) & (US$ Million)
Table 73. Charles River Laboratories Recent Development
Table 74. uniQure N.V. Company Details
Table 75. uniQure N.V. Business Overview
Table 76. uniQure N.V. Gene Vector Product
Table 77. uniQure N.V. Revenue in Gene Vector Business (2020-2025) & (US$ Million)
Table 78. uniQure N.V. Recent Development
Table 79. FUJIFILM Diosynth Biotechnologies Company Details
Table 80. FUJIFILM Diosynth Biotechnologies Business Overview
Table 81. FUJIFILM Diosynth Biotechnologies Gene Vector Product
Table 82. FUJIFILM Diosynth Biotechnologies Revenue in Gene Vector Business (2020-2025) & (US$ Million)
Table 83. FUJIFILM Diosynth Biotechnologies Recent Development
Table 84. Spark Therapeutics, Inc. Company Details
Table 85. Spark Therapeutics, Inc. Business Overview
Table 86. Spark Therapeutics, Inc. Gene Vector Product
Table 87. Spark Therapeutics, Inc. Revenue in Gene Vector Business (2020-2025) & (US$ Million)
Table 88. Spark Therapeutics, Inc. Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
Table 92. Authors List of This Report


List of Figures
Figure 1. Gene Vector Picture
Figure 2. Global Gene Vector Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Gene Vector Market Share by Type: 2024 VS 2031
Figure 4. Lentivirus Features
Figure 5. Adenovirus Features
Figure 6. Adeno-associated Virus (AAV) Features
Figure 7. Plasmid DNA Features
Figure 8. Others Features
Figure 9. Global Gene Vector Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Gene Vector Market Share by Application: 2024 VS 2031
Figure 11. Scientific Research Case Studies
Figure 12. CRO Case Studies
Figure 13. CDMO Case Studies
Figure 14. Others (Pharmaceutical, Biotechnology Companies) Case Studies
Figure 15. Gene Vector Report Years Considered
Figure 16. Global Gene Vector Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Gene Vector Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Gene Vector Market Share by Region: 2024 VS 2031
Figure 19. Global Gene Vector Market Share by Players in 2024
Figure 20. Global Top Gene Vector Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Vector as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Gene Vector Revenue in 2024
Figure 22. North America Gene Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Gene Vector Market Share by Country (2020-2031)
Figure 24. United States Gene Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Gene Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Gene Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Gene Vector Market Share by Country (2020-2031)
Figure 28. Germany Gene Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Gene Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Gene Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Gene Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Gene Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Gene Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Gene Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Gene Vector Market Share by Region (2020-2031)
Figure 36. China Gene Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Gene Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Gene Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Gene Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Gene Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Gene Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Gene Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Gene Vector Market Share by Country (2020-2031)
Figure 44. Mexico Gene Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Gene Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Gene Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Gene Vector Market Share by Country (2020-2031)
Figure 48. Turkey Gene Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Gene Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Gene Vector Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Lonza Revenue Growth Rate in Gene Vector Business (2020-2025)
Figure 52. Merck KGaA Revenue Growth Rate in Gene Vector Business (2020-2025)
Figure 53. Oxford Biomedica Revenue Growth Rate in Gene Vector Business (2020-2025)
Figure 54. CGT Catapult Revenue Growth Rate in Gene Vector Business (2020-2025)
Figure 55. Charles River Laboratories Revenue Growth Rate in Gene Vector Business (2020-2025)
Figure 56. uniQure N.V. Revenue Growth Rate in Gene Vector Business (2020-2025)
Figure 57. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Gene Vector Business (2020-2025)
Figure 58. Spark Therapeutics, Inc. Revenue Growth Rate in Gene Vector Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies